ACE-536
Showing 51 - 75 of 545
Alport Syndrome, Focal Segmental Glomerulosclerosis Trial in United States (R3R01)
Recruiting
- Alport Syndrome
- Focal Segmental Glomerulosclerosis
-
Los Angeles, California
- +10 more
Aug 15, 2022
Carcinoma, Hepatocellular Trial in Hong Kong (Ablative chemoembolization (ACE))
Recruiting
- Carcinoma, Hepatocellular
- Ablative chemoembolization (ACE)
-
Hong Kong, Hong KongDepartment of Imaging and Interventional Radiology, Prince of Wa
Mar 10, 2022
Cardiovascular Risk Factor, Covid19 Trial in Amman (300 mg of omega3-FA)
Completed
- Cardiovascular Risk Factor
- Covid19
- 300 mg of omega3-FA
-
Amman, JordanMahmoud S Abu-Samak
Feb 23, 2022
Energy Intake, Gastrointestinal Hormones, Glycemic Control Trial in Basel (Xylitol, Sucrose, Acesulfame Potassium)
Not yet recruiting
- Energy Intake
- +4 more
- Xylitol
- +3 more
-
Basel, SwitzerlandSt. Claraspital
Dec 20, 2022
Burnout, Professional, Dementia, Quality of Life Trial in Lugano (I-ACE training, Standard non-pharmacological therapies (NPT)
Recruiting
- Burnout, Professional
- +2 more
- I-ACE training
- Standard non-pharmacological therapies (NPT) training
-
Lugano, Canton Ticino, SwitzerlandNuring Homes of Canton Ticino area
Jan 24, 2023
HER2 Mutation-Related Tumors, HER2 Amplified Solid Tumors Trial in Miami Beach, Kansas City (ARX788)
Withdrawn
- HER2 Mutation-Related Tumors
- HER2 Amplified Solid Tumors
-
Miami Beach, Florida
- +1 more
Apr 22, 2022
Healthy Volunteer Trial in Hamilton (Japanese-translated evidence summaries (Advanced Clinical Evidence report from
Completed
- Healthy Volunteer
- Japanese-translated evidence summaries (Advanced Clinical Evidence report from OrthoEvidence)
- English evidence summaries (Advanced Clinical Evidence report from OrthoEvidence)
-
Hamilton, Ontario, CanadaMcMaster University
Jul 30, 2022
IgA Nephropathy (IgAN), Berger Disease, Glomerulonephritis, IgA Trial in Worldwide (Placebo, Cemdisiran)
Active, not recruiting
- IgA Nephropathy (IgAN)
- +2 more
- Placebo
- Cemdisiran
-
Vancouver, British Columbia, Canada
- +19 more
Jan 13, 2023
COVID-19 Trial in Istanbul (Biological/Vaccine: Angiotensin peptide (1-7) derived plasma)
Completed
- COVID-19
- Biological/Vaccine: Angiotensin peptide (1-7) derived plasma
-
Istanbul, TurkeyKanuni Sultan Suleyman Training and Research Hospital
Mar 30, 2022
Patient-Specific 3D Electro-Anatomical Heart Model in VT
Terminated
- Ischemic Monomorphic Ventricular Tachycardia
- Supporting information.
-
Philadelphia, PennsylvaniaUpenn
Oct 17, 2022
Pulmonary Arterial Hypertension Trial in Worldwide (Placebo, Sotatercept)
Completed
- Pulmonary Arterial Hypertension
- Placebo
- Sotatercept
-
Phoenix, Arizona
- +42 more
Jan 11, 2023
Charcot-Marie-Tooth Disease Trial in United States (ACE-083, Placebo)
Adverse Childhood Experiences and Infertility : ACESI
Not yet recruiting
- Infertility, Female
- +4 more
- ACE Questionnaire
- (no location specified)
Jul 18, 2023
Angioedema Caused by Angiotensin-Converting-Enzyme Inhibitor Trial in Saint Louis (High ACE Activity Fresh Frozen Plasma, Normal
Recruiting
- Angioedema Caused by Angiotensin-Converting-Enzyme Inhibitor
- High ACE Activity Fresh Frozen Plasma
- Normal Saline
-
Saint Louis, MissouriBarnes-Jewish Hospital
Oct 24, 2022
Tumors Trial in Sarasota (Hands-free, user-controlled robotic system intended to assist in the planning and advancement of an
Recruiting
- Tumors
- Hands-free, user-controlled robotic system intended to assist in the planning and advancement of an instrument during CT guided percutaneous procedures. T
-
Sarasota, FloridaSarasota Interventional Radiology
Oct 21, 2021
Hypertension Trial in London (Preoperative ACEi/ARB management)
Completed
- Hypertension
- Preoperative ACEi/ARB management
-
London, Ontario, CanadaLondon Health Sciences Centre
Oct 21, 2021
Metastatic Castration Resistant Prostate Cancer Trial in Switzerland, United Kingdom (AZD5069, Enzalutamide 40 MG)
Active, not recruiting
- Metastatic Castration Resistant Prostate Cancer
- AZD5069
- Enzalutamide 40 MG
-
Bellinzona, Switzerland
- +3 more
Mar 18, 2022
Peripheral Arterial Disease, Intermittent Claudication, Hypertension Trial in São Paulo (Arm ergometer, Treadmill ergometer,
Recruiting
- Peripheral Arterial Disease
- +2 more
- Arm ergometer
- +2 more
-
São Paulo, BrazilHospital Israelita Albert Einstein
Dec 6, 2021
Breast Cancer, Cardiotoxicity Trial in Florence (Bisoprolol, Ramipril, Placebo)
Active, not recruiting
- Breast Cancer
- Cardiotoxicity
- Bisoprolol
- +2 more
-
Florence, ItalyAzienda Ospedaliero-Universitaria Careggi, Florence University
Jan 16, 2022
Facioscapulohumeral Muscular Dystrophy, Charcot-Marie-Tooth Disease Trial in Canada, Spain, United States (ACE-083)
Terminated
- Facioscapulohumeral Muscular Dystrophy
- Charcot-Marie-Tooth Disease
-
Orange, California
- +23 more
Sep 13, 2022
Hypertension, COVID-19 Trial in Kiev (Angiotensin converting enzyme inhibitor, Angiotensin Receptor Blockers, Direct renin
Completed
- Hypertension
- COVID-19
- Angiotensin converting enzyme inhibitor
- +2 more
-
Kiev, Please Select, UkraineMedical Practice Prof D.Ivanov
Feb 16, 2022
Tumors Trial in Calgary, Edmonton (Exercise)
Recruiting
- Neoplasms
- Exercise
-
Calgary, Alberta, Canada
- +1 more
Jul 26, 2022
Spinal Cord Injuries Trial in Miami (Seated control (CON), Arm cycle exercise (ACE), Liquid meal)
Suspended
- Spinal Cord Injuries
- Seated control (CON)
- +2 more
-
Miami, FloridaLois Pope Life Center
May 27, 2022
Pulmonary Arterial Hypertension Trial in Worldwide (Sotatercept, Placebo)
Recruiting
- Pulmonary Arterial Hypertension
- Sotatercept
- Placebo
-
Los Angeles, California
- +39 more
Aug 5, 2022